Thomas P. Miller, MD, named director of the Division of Hematology/Oncology
Thomas P. Miller, MD
Thomas P. Miller, MD, has been named the director of the Division of Hematology/Oncology in the UA College of Medicine’s Department of Medicine.
Dr. Miller currently serves as a professor of medicine in the College of Medicine and is a member of the University of Arizona Cancer Center's Lymphoma Program.
“Dr. Miller brings to the position his extensive experience in clinical research that has changed the standard of practice for lymphoma,” said UA Cancer Center interim director Anne Cress, PhD. “He will directly support our priority to increase innovative clinical research to impact patient care. We anticipate research-active faculty recruitments and a robust research fellowship program.”
“Many thanks to Dr. Michael A. Bookman for his past four years of service in this role,” Dr. Cress said.
Dr. Miller joined the University of Arizona as one of the Cancer Center’s first fellows in 1977. Dr. Miller’s mentors — Sydney E. Salmon, MD; Brian Durie, MD; David S. Alberts, MD; and Stephen E. Jones, MD — formed the UA’s first Section of Hematology/Oncology. He joined the UACC faculty in 1980, where he has pioneered groundbreaking translational research and redefined the standard of care for lymphoma patients worldwide.
He has been the principal investigator for the UA Cancer Center’s Southwest Oncology Group Program for 27 years, and he is the co-principal investigator of the Specialized Program of Research Excellence (SPORE) in Lymphoma, a partnership between the UACC’s Lymphoma Research Consortium and the University of Rochester James P. Wilmot Cancer Center.
Under Dr. Miller’s direction, the UA Cancer Center’s Lymphoma Program has been an internationally recognized leader in the study of lymphomas and has been critical in advancing the standard of care for patients with lymphoma. The program coordinates the largest lymphoma tissue bank in the world, with more than 10,000 specimens.
Dr. Miller received his medical degree from the University of Illinois, Chicago. He completed his internship and residency at the University of Illinois Hospitals and his three-year fellowship in medical oncology at The University of Arizona.
Dr. Miller’s research has focused on exploring the significance of cellular proteins using a variety of techniques, including immunohistochemistry. His clinical work has been directed toward improving therapy for lymphoma.